Nanomedicine for ClarithromycinFrom
OPPORTUNITYAccording to Chinese Business Association reported that in 2007, with erythromycin-based macrolide antibiotics, total global sales of more than 90 million sales of clarithromycin in the global market has risen to 15 billion U.S. dollars, accounting for international macrolide antibiotics 18% of total sales, of which Abbott's patent-name drugs clarithromycin only half of the remaining shares are contributed by imitation. Because clarithromycin Preparation Popular hospital in the country, the domestic pharmaceutical manufacturers spotted the opportunity to develop the production of clarithromycin
Join us to take NanoClarithromycin to Clinic
What is Needed?
Emulsifier is an egg phosphatide. No Need of It!
Bio-available at all pH in all parts of digestive system in oral delivery formulations. pH independence needed.
Soybean oil, an egg phosphatide, oleic acid, hexanoic acid and glycerin elimination fro formulations. Zero Need Of It!
An effective, safe and most inexpensive nanomedicine for Clarithromycin. It is Needed!
To eliminate acids from formulation. Take It out !
A Genuine need is fulfilled
PROBLEMClarithromycin has relatively low solubility in water. Consequently, a tablet that comprises Clarithromycin and a water soluble filler such as sorbitol, without any disintegrant will dissolve too slowly to enable full release of the Clarithromycin after ingestion.
No Nanomedicine formulation developed so far.
Issues & NeedsIt has been found that erythromycin fat emulsions are locally non-irritative. The antibiotic clarithromycin, however, has a low solubility in fat emulsions even in the presence of oils, and will precipitate out of such emulsions. It has heretofore not been possible to solubilize clarithromycin so as to achieve stable injectable compositions at concentrations which are high enough for therapeutically effective pharmaceutical purposes.
There is a continuing need for stable injectable compositions of clarithromycin at therapeutically acceptable concentrations that do not cause severe pain at the injection site.
A genuine Project for investment
What is new?Present invention releases drug at all pH and faster than any existing formulation.
Invention for nanomedicine
Patented nanomedicine to prevent generic cliff
Most inexpensive manufacturing of nanomedicines.
Your manufacturing set-up remains same.
Why the market so big( $15Billion Market?)
We stay away from Me-too
Click hyperlink to see our customers
Our customers for NanoClarithromycin
Join us to take this discovery to Clinic
What has been Established
SOP for pilot scale production
Analytical testing procedures for testing
Funds ForTo move in cGMP manufacturing
Alexander Project USA 2000
PK/PD breakpoint based on current approved
Susceptible breakpoint NCCLS PK/PDS. pneumoniae H. influenzae ALL
Clarithromycin 0.25 8 0.25
Solubility is a genuine needResolved by Meda Biotech llc.
1. New molecule MR007 for nanoparticle2. MR007 provides synergistic3. Lowest manufacturing cost4. Strong patent5. No need of existing facility change6. No need to hire new staff
Tablets Stable and 10X more potent
Nanomedicine for all